American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units
BOCA RATON, Fla, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy (SRT), reports that the American Society of Radiologic Technologists (ASRT) has approved Sensus Healthcares SRT Systems for Continuing Education Units (CEUs).
- BOCA RATON, Fla, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy (SRT), reports that the American Society of Radiologic Technologists (ASRT) has approved Sensus Healthcares SRT Systems for Continuing Education Units (CEUs).
- Now that the ASRT has recognized the Companys training with CEUs, the American Registry of Radiologic Technologists (ARRT) automatically recognizes Sensus Healthcare training as a legitimate provider for CEUs.
- The ARRT requires Registered Technologists to complete and report 24 credits of approved continuing education activities every two years to maintain their registration.
- By recognizing Sensus as a provider for CEUs, our SRT systems can now enjoy further validation of the importance of SRT for the treatment of non-melanoma skin cancer.